Advanced Lung Cancer
22
Sep
A Phase 3, open-label, randomized, active-controlled, multicenter trial to evaluate the efficacy and safety of orally administered BA...
Early Stage Lung Cancer
21
Sep
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer (BGB-LC-201)
Be...